ConductScience.org, home

Paper20071683

Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study.

Yasuda M and 7 others. Invest Ophthalmol Vis Sci, 2010. Cited by 84 papers, by iCite.

Cite this record

ConductScience Library. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Papers, record 20071683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20071683

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study.
PubMed
Journal
Invest Ophthalmol Vis Sci
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
2.62
iCite
Revised in PubMed
2022-12-07
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yasuda MMiho
2Kiyohara YYutaka
3Arakawa SSatoshi
4Hata YYasuaki
5Yonemoto KKoji
6Doi YYasufumi
7Iida MMitsuo
8Ishibashi TTatsuro

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Asian PeopleMajor topic
Retinal Vein OcclusionMajor topic
Adult
Age Distribution
Aged
Aged, 80 and over
Blood Glucose
Blood Pressure
Cross-Sectional Studies
Female
Hematocrit
Humans
Hypertension
Japan
Male
Middle Aged
Odds Ratio
Prevalence
Prospective Studies
Risk Factors
Sex Distribution

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
42880818Non-inferiority study of the efficacy of ranibizumab BS compared with aflibercept in patients with macular oedema due to untreated branch retinal vein occlusion: REMEDY-BRVO study - study protocol.BMJ Open Ophthalmol2026https://conductscience.org/library/papers/42880818PubMed
42115364Increased prevalence of hearing loss and tinnitus in patients with retinal vein occlusion.Sci Rep2026https://conductscience.org/library/papers/42115364PubMed
42018115Branch retinal vein occlusion in Leber hereditary optic neuropathy with onset at age 50 years or older: frequency and clinical characteristics.Jpn J Ophthalmol2026https://conductscience.org/library/papers/42018115PubMed
41940529Associations of nutritional intake and body mass index with branch retinal vein occlusion: A cross-sectional study using data from a Korean national survey.Sci Prog2026https://conductscience.org/library/papers/41940529PubMed
41835289Optimal Treatment of Retinal Vein Occlusion: An Updated Canadian Review and Recommendations.Clin Ophthalmol2026https://conductscience.org/library/papers/41835289PubMed
41790764Hemodynamic instability and retinal vein occlusion in glaucoma: Comparative analysis of heart rate variability and choroidal perfusion.PLoS One2026https://conductscience.org/library/papers/41790764PubMed
41476123The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertens Res2026https://conductscience.org/library/papers/41476123PubMed
41375850Development of an Algorithm to Assist in the Diagnosis of Combined Retinal Vein Occlusion and Glaucoma.J Clin Med2025https://conductscience.org/library/papers/41375850PubMed
40195975Risk factors of retinal vein occlusion in East Asia: a meta-analysis.Front Ophthalmol (Lausanne)2025https://conductscience.org/library/papers/40195975PubMed
39648855Causal association between glaucoma and risk of retinal vascular occlusion: a Mendelian randomization study.J Int Med Res2024https://conductscience.org/library/papers/39648855PubMed
39204083New Therapeutic Strategies in Retinal Vascular Diseases: A Lipid Target, Phosphatidylserine, and Annexin A5-A Future Theranostic Pairing in Ophthalmology.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39204083PubMed
39132113Demographic profile, prevalence, pattern, and risk factors for retinal vein occlusion in Liberia: A retrospective study.Oman J Ophthalmol2024https://conductscience.org/library/papers/39132113PubMed
39105547Prevalence and risk factors of retinal vein occlusion in individuals with diabetes: The kailuan eye study.Diab Vasc Dis Res2024https://conductscience.org/library/papers/39105547PubMed
39043891Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion.Sci Rep2024https://conductscience.org/library/papers/39043891PubMed
38409518Vision-related quality of life in patients with retinal vein occlusion.Int Ophthalmol2024https://conductscience.org/library/papers/38409518PubMed
38096214Maximum carotid intima-media thickness and NT-pro BNP in association with retinal vein occlusion.PLoS One2023https://conductscience.org/library/papers/38096214PubMed
37408057Are inner nuclear layer ischemic lesions hidden indicators of retinal vein occlusion risk? A case-control study.Int J Retina Vitreous2023https://conductscience.org/library/papers/37408057PubMed
37223029Mendelian randomization indicates a causal contribution of type 2 diabetes to retinal vein occlusion.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37223029PubMed
37091777Prevalence and risk factors of retinal vein occlusion in the United States: The National Health and Nutrition Examination Survey, 2005 to 2008.Proc (Bayl Univ Med Cent)2023https://conductscience.org/library/papers/37091777PubMed
37061579Novel superpixel method to visualize fundus blood flow resistivity in healthy adults.Sci Rep2023https://conductscience.org/library/papers/37061579PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20071683

GET https://conductscience.org/api/papers/v1/20071683/cited_by?page=2